Altimmune (NASDAQ:ALT) executives highlighted clinical progress across multiple pemvidutide programs and discussed the ...

A good three-point shot starts before the ball leaves your hands. It begins lower, with bent hips, knees and ankles, and with ...

Dimerix to conduct blinded review of ACTION3 data later this month to confirm statistical assumptions for primary endpoint ... Read More The post Dimerix to conduct blinded review of phase III kidney ...

Good morning, and welcome to Biofrontera Inc.'s fourth quarter and full year 2025 financial results and business update conference call. Please note that certain information discussed during today's ...

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

On World Kidney Day, Newsweek explores how one country is testing whether early detection can slow a global epidemic.

Israel’s military chief said it’s moving to the “next phase” of the war with Iran after carrying out 2,500 strikes with more than 6,000 weapons. Follow for live updates. Follow for live updates.

Corporations have scrambled to adopt AI in the workplace. Now they are measuring how well their employees actually understand it.

From the 1991 CRZ notification to World Bank-backed ICZM, India’s coastal governance has moved from environmental safeguards ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.

A proposal to establish new hotel zoning districts — a move that would allow roughly 4,500 short-term vacation rentals to ...